Oracle files for $20 billion in stock and debt sales as AI financing pressure grows

Oracle took a concrete step toward financing its AI infrastructure buildout on November 2, 2026, filing to sell $10 billion in common stock and issue $10 billion in senior notes. Shares fell 8.8% that day, even though the company had outlined the financing the previous week—a contrast between management’s funding plan and investors’ reception.

A financing filing, not cash already raised

The Securities and Exchange Commission filings put the combined planned offerings at $20 billion. They represent proposed stock and debt sales, not a completed fundraising. CNBC reported that Oracle intends to use the proceeds for general corporate purposes, potentially including capital expenditures, debt repayments and future investments. That leaves the money available for several uses rather than reserving the entire amount for AI infrastructure.

The amounts match the financing framework management presented at its October 28 investor day. Oracle said it would limit additional capital raises through fiscal 2030 to $20 billion, excluding refinancing of existing debt. The split was equal: $10 billion in equity and $10 billion in gross debt. Monday’s filings therefore advance an already disclosed plan rather than introduce a larger funding target.

Two funding sources, different shareholder costs

01$10 billion

Common stock

Selling new shares could dilute existing shareholders’ ownership.

02$10 billion

Senior notes

Issuing the notes would add to Oracle’s borrowing obligations.

A selloff alongside qualified optimism

Oracle closed November 2 at $119.22, according to TheStreet. The decline came against existing concern about the debt needed to finance AI infrastructure. CNBC reported that both Oracle’s stock and bonds had already been under pressure over that issue. The day’s closing loss was sharper than the 3% premarket decline CNBC recorded after the filing.

Not every assessment of the financing outlook was as negative. TheStreet, citing The Fly, reported that Scotiabank viewed Oracle’s major financing overhang as beginning to clear after the investor day. The bank remained optimistic about the company’s position in AI infrastructure, although it lowered its price target while retaining an Outperform rating.

Wells Fargo’s assessment put more emphasis on execution. It maintained an Overweight rating but questioned Oracle’s ability to meet its fiscal 2030 targets, TheStreet reported. Its focus included capital spending, financing requirements, and how customer-provided hardware and prepayments could support growth. Those are different questions from whether Oracle can simply arrange another stock or bond sale.

Management’s payoff lies beyond the offering

Oracle’s own case rests on a later improvement in cash generation. The company expects to turn free cash flow positive in the second half of fiscal 2028, then generate more than $30 billion in fiscal 2029. It also expects to fund growth internally beginning in fiscal 2029. These are management forecasts, not cash the current business has already delivered.

The growth targets are substantial. Oracle is aiming for more than $225 billion in annual revenue by fiscal 2030, alongside a non-GAAP operating margin above 40% and adjusted earnings above $21 a share. For fiscal 2027, it reaffirmed revenue guidance of at least $90 billion and adjusted earnings of $8.10 a share.

The next scheduled earnings report is December 14. That gives investors another checkpoint on the business behind the financing plan: an infrastructure expansion requiring heavy investment now, with management’s promised shift toward internally funded growth still several fiscal years away.